Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lantheus Holdings, Inc. | 7,004,395 | reported | 17 Mar 2017 | tx 6−5,500,000 |
| OptiNose, Inc. | 14,439 | reported | 10 Jun 2020 | tx 27+18,299,722−10,159,045 |
| Osmotica Pharmaceuticals plc | 0 | reported | 27 Jan 2023 | tx 4+9,250,000−5,969,921 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Jan 2023 | OTHER | Osmotica Pharmaceuticals plc | 1,032,995 | 0.00 USD | |
| 08 Aug 2022 | PURCHASE | Osmotica Pharmaceuticals plc | 8,000,000 | 1.55 USD | first after silence |
| 20 Nov 2020 | OTHER | Osmotica Pharmaceuticals plc | 4,936,926 | — | |
| 10 Jun 2020 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 5.65 USD | deriv |
| 13 Jan 2020 | PURCHASE | Osmotica Pharmaceuticals plc | 1,250,000 | 5.00 USD | |
| 25 Nov 2019 | SALE | OptiNose, Inc. | 887,722 | 9.17 USD | |
| 25 Nov 2019 | SALE | OptiNose, Inc. | 70,762 | 9.17 USD | |
| 25 Nov 2019 | SALE | OptiNose, Inc. | 291,516 | 9.17 USD | |
| 06 Jun 2019 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 6.60 USD | deriv |
| 11 Jun 2018 | SALE | OptiNose, Inc. | 2,041,759 | 20.92 USD | |
| 11 Jun 2018 | SALE | OptiNose, Inc. | 670,487 | 20.92 USD | |
| 11 Jun 2018 | SALE | OptiNose, Inc. | 162,754 | 20.92 USD | |
| 07 Jun 2018 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 22.50 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 962,735 | — | |
| 17 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 887,721 | 16.00 USD | |
| 17 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 291,516 | 16.00 USD | |
| 17 Oct 2017 | GRANT_AWARD | OptiNose, Inc. | 70,763 | 16.00 USD | |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 12,077,563 | — | |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 3,966,107 | — | |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 17,233 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 216,189 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 354,855 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 216,189 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 28,286 | 0.00 USD | deriv |
| 17 Oct 2017 | CONVERSION | OptiNose, Inc. | 116,529 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 08 Aug 2022.